Factor XIa Tied to Benefit Beyond Stroke Prevention
-
Results from the OCEANIC-STROKE trial show that the investigational Factor
XIa inhibitor, asundexian, not only reduces the recurrent ischaemic stroke
risk,...
18 hours ago